Electronic Beat For Medical Devices

02/10/2023

https://m.facebook.com/story.php?story_fbid=631901485821917&id=100070062137478&mibextid=Nif5oz

21/05/2020

May 20, 2020 — Acutus Medical and Biotronik announced a new alliance to provide a comprehensive portfolio of electrophysiology, mapping, ablation and accessory products for catheter-based treatment of cardiac arrhythmias across select markets, including Europe and Asia.

18/09/2019

https://www.biotronik.com/en-de/newsroom/press-releases/press-release-first-mdr-sep18-en

The First Class III Medical Device is Certified Under the New European Medical Device Regulation

11/09/2019

https://www.prnewswire.com/news-releases/superiority-of-orsiro-over-xience-demonstrated-in-stemi-patients-late-breaking-data-at-esc-300910762.html

PARIS and LAKE OSWEGO, Ore., Sept. 3, 2019 /PRNewswire/ -- BIOTRONIK's ultrathin Orsiro® stent demonstrated superiority over Xience with respect to target...

24/05/2019

https://www.cathlabdigest.com/content/late-breaking-data-europcr-biotroniks-orsiro-demonstrates-unique-benefits-small-vessels

A Subgroup Analysis of the BIO-RESORT RCT Three-Year Data Showed Significant Differences in Efficacy in Favor of Ultrathin Strut Orsiro

14/03/2019

https://www.prnewswire.com/news-releases/fda-approves-industrys-smallest-slimmest-3t-tachycardia-devices-from-biotronik-300812700.html

LAKE OSWEGO, Ore., March 14, 2019 /PRNewswire/ -- BIOTRONIK today announced FDA approval of the Acticor and Rivacor high-voltage cardiac rhythm management...

11/03/2019

BIOTRONIK Launches the World’s Smallest 3T Full-Body MR Conditional ICD and CRT-D Devices on the European Market
The Acticor and Rivacor Families Feature an Ultraslim BIOshape as well as Extended Battery Life and Warranty

BIOTRONIK Launches the World’s Smallest 3T Full-Body MR Conditional ICD and CRT-D Devices on the European Market

22/02/2019

https://www.prnewswire.com/news-releases/fda-approves-biotroniks-ultrathin-orsiro-stent-for-the-treatment-of-coronary-artery-disease-300800442.html

LAKE OSWEGO, Ore., Feb. 22, 2019 /PRNewswire/ -- BIOTRONIK today announced FDA approval of the Orsiro drug-eluting stent (DES) system. Orsiro is the first and...

25/01/2019

https://youtu.be/4pPxlFEA03I

BIOTRONIK’s PK Papyrus covered stent system is designed to treat acute coronary artery perforations. This video demonstrates PK Papyrus’s key technical featu...

27/09/2018

Experts were reassured by the safety of the device and want to see polymer-free BioFreedom stent tested in high-bleeding-risk patients.

27/09/2018

TCT Congress 2018: BIOTRONIK's Orsiro Ultrathin Drug-Eluting Stent Further Outperforms Xience at Two-Year Follow-Up

Randomized Controlled Trial Data Presented at TCT Continues to Show Significantly Lower Event Rates with Orsiro in the BIOFLOW-V Trial

27/09/2018

BARCELONA, Spain, Aug. 28, 2017 /PRNewswire/ -- BIOTRONIK today announced data from the BIOFLOW-V randomized trial comparing Orsiro* and Xience** drug-eluti...